Prevalence of hyperapobetalipoproteinemia and factors affecting the phenotype expression in children and young adults: The Cardiovascular Risk in Young Finns Study

Atherosclerosis

Volumn 122, Issue 1, 1996, Pages 79-88

  Nuotio, Ilpo O ^a   Porkka, Kimmo V K ^b   Raitakari, Olli T ^a   Lehtimäki, Terho ^c   Marniemi, Jukka ^d   Taimela, Simo ^a   Suurinkeroinen, Leena ^b   Viikari, Jorma S A ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^d SOCIAL INSURANCE INSTITUTION   (Finland)

Author keywords

Alcohol; Children; Hyperapobetalipoproteinemia; Lipids; Lipoproteins; Or l contraceptives; Smoking

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CONTRACEPTION; CORONARY ARTERY DISEASE; FEMALE; FINLAND; HUMAN; LIFESTYLE; MALE; NORMAL HUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SMOKING;

EID: 0029937799     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05751-X     Document Type: Article

References (50)

1. Anon. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group. J Am Med Assoc 1990;264:3018-3024.
2. Newman WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. New Engl J Med 1986;314:138-144.
3. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density beta lipoproteins]. Proc Natl Acad Sci USA 1980:77:604-608.
4. Kwiterovich P, Beaty T, Bachorik P, Chen J, Franklin F, Georgopoulos L, Sniderman A. Pediatrix hyperlipoproteinemia: the phenotypic expression of hyperapobetalipoproteinemia in young probands and their parents. Prog Clin Biol Res 1988;255:89-105.
5. Sniderman A, Teng B, Genest J, Cianflone K, Wacholder S, Kwiterovich PO Jr. Familial aggregation and early expression of hyperapobetalipoproteinemia. Am J Cardiol 1985;55:291-295.
6. Sniderman AD, Wolfson C, Teng B, Franklin FA. Bachoric PS, Kwiterovich PO Jr. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med 1982;97:833-839.
7. Kwiterovich PO Jr, White S, Forte T, Bachorik PS, Smith H, Sniderman A. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis 1987;7:211-225.
8. Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 1983;24:147-155.
9. Hokanson JE, Austin MA, Zambon A, Brunzell JD. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb 1993;13:427-434.
10. Teng B, Sniderman AD, Soutar AK, Thompson GR. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest 1986;77:663-672.
11. Venkatesan S, Cullen P, Pacy P. Halliday D, Scott J. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 1993;13:1110-1118.
12. Kwiterovich PO Jr. HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. Clin Chem 1988;34:B71-B77.
13. Kwiterovich PO Jr, Motevalli M, Miller M. The effect of three basic proteins on the mass of lipids in normal and hyperapoB fibroblasts. Arterioscler Thromb 1994;14:1-7.
14. Kelly DR, Hoeg JM, Demosky SJ Jr, Brewer HB Jr. Characterization of plasma lipids and lipoproteins in cholesteryl ester storage disease. Biochem Med 1985;33:29-37.
15. Kwiterovich PO Jr. Genetics and molecular biology of familial combined hyperlipidemia. Curr Opin Lipidol 1993;4:133-143.
16. Sniderman A, Brown BG, Stewart F, Cianflone K. From familial combined hyperlipidemia to hyperapoB: unravelling the overproduction of hepatic apolipoprotein B. Curr Opin Lipidol 1992;3:137-142.
17. Genest JJ Jr, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson PW, Salem DN, Schaefer EJ. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992;85:2025-2033.
18. Kwiterovich PO Jr, Coresh J, Bachorik PS. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women ( < or = 60 years) with coronary artery disease. Am J Cardiol 1993;71:631-639.
19. Wilcken DE, Wang XL, Greenwood J, Lynch J. Lipoprotein(a) and apolipoproteins B and A-I in children and coronary vascular events in their grandparents. J Pediatr 1993;123:519-526.
20. Beigel Y, George J, Leibovici L, Mattiyahu A, Sclarovsky S, Blieden L. Coronary risk factors in children of parents with premature coronary artery disease. Acta Paediatr 1993;82:162-165.
21. Freedman DS, Srinivasan SR, Shear CL, Franklin FA, Webber LS, Berenson GS. The relation of apolipoproteins A-I and B in children to parental myocardial infarction. New Engl J Med 1986;315:721-726.
22. Åkerblom HK, Viikari J, Uhari M, Räsänen L, Byckling T, Louhivuori K, Pesonen E, Suoninen P, Pietikäinen M, Lähde P-L, Dahl M, Aromaa A, Sarna S, Pyörälä K. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatr Scand 1985;Suppl 318:49-63.
23. Åkerblom HK, Viikari J, Räsänen L, Kuusela V, Uhari M, Lautala P. Cardiovascular risk in young Finns, results from the second follow-up study. Ann Med 1989;21:223-225.
24. 2+/dextran sulphate in its enzymatic measurement. Clin Chem 1978;24:931-937.
25. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
26. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins Al and B in serum. Scand J Clin Lab Invest 1987;47:739-747.
27. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965;25:1375-1384.
28. Dahlström S, Viikari J, Åkerblom HK, Solakivi-Jaakkola T. Uhari M, Dahl M. Lähde PL, Pesonen L, Pietikäinen M, Suoninen P, Louhivuori K. Atherosclerosis precursors in Finnish children and adolescents. II. Height, weight, body mass index, and skinfolds, and their correlation to metabolic variables. Acta Paediatr Scand 1985;Suppl 318:65-78.
29. Uhari M. Nuutinen EM, Turtinen J, Pokka T, Kuusela V, Akerblom HK, Dahl M, Kaprio EA, Pesonen E, Pietikäinen M, Salon MK, Viikari J. Blood pressure in children, adolescents and young adults. Ann Med 1991;23:47-51.
30. SAS Institute Inc. SAS/STAT User's Guide. Cary, NC: SAS Institute Inc., 1988.
31. Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO Jr. Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci USA 1983;80:6662-6666.
32. Genest J, Sniderman A, Cianflone K, Teng B, Wacholder S, Marcel Y, Kwiterovich P Jr. Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load. Arteriosclerosis 1986;6:297-304.
33. Sniderman A, Vu H, Cianflone K. Effect of moderate hypertrigyceridemia on relation of plasma total and LDL apo B levels. Atherosclerosis 1991;89:109-116.
34. Raitakari OT, Porkka KVK, Räsänen L, Viikari JSA. Relations of lifestyle with lipids, blood pressure and insulin in adolescent and young individuals. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 1994;111:237-246.
35. Croft JB, Freedman DS, Cresanta JL, Srinivasan SR, Burke GL, Hunter SM, Webber LS, Smoak CG, Berenson GS. Adverse influences of alcohol, tobacco, and oral contraceptives use on cardiovascular risk factors during transition to adulthood. Am J Epidemiol 1987;126:202 213.
36. Vaziri SM, Evans JC, Larson MG, Wilson PWF. The impact of female hormone usage on the lipid profile. The Framingham Offspring Study. Arch Intern Med 1993;153:2200-2206.
37. Leuven JA, Dersjant-Roorda MC, Helmerhorst FM, de Boer R, Neymeyer-Leloux A, Havekes LM. Effects of oral contraceptives on lipid metabolism. Am J Obstet Gynecol 1990;163:1410-1413.
38. Kuhl H, März W, Jung-Hoffmann C, Weber J, Siekmeier R, Gross W. Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive: divergent changes in apolipoprotein B and E and transitory decrease in lp(a) levels. Contraception 1993;47:69-83.
39. Burkman RT, Zacur HA, Kimball AW, Kwiterovich PO, Bell WR. Oral contraceptives and lipids and lipoproteins: part II relationship to plasma steroid levels and outlier status. Contraception 1989;40:675-689.
40. Leuven JAG, Dersjant-Roorda MC, Helmerhorst FM, de Boer R, Neymeyer-Leloux A, Havekes L. Estrogenic effect of getodene-or desogestrel-containing oral contraceptives on lipoprotein metabolism. Am J Obstet Gynecol 1990;163:358-362.
41. Srinivasan SR, Wattigney W, Webber LS, Berenson GS. Relation of cholesterol to apolipoprotein B in low density lipoproteins of children. The Bogalusa Heart Study. Arteriosclerosis 1989;9:493-500.
42. Puchois P, Ghalim N. Zylberberg G, Fievet P, Demarquilly C, Fruchart JC. Effect of alcohol intake on human apolipoprotein A-I-containing lipoprotein subfractions. Arch Intern Med 1990;150:1638-1641.
43. Lamon-Fava S, Jiminez D, Christian JC, Fabsitz RR, Reed T, Carmelli D, Castelli WP, Ordovas JM, Wilson PWF, Schaefer EJ. The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis 1991;91:97-106.
44. Gomo ZAR. The effect of age, sex, alcohol consumption and cigarette smoking on serum concentrations of lipids and apolipoproteins in Zimbabwean blacks. Atherosclerosis 1986;61:149-154.
45. Little JA, Graves K, Suchindran CM, Milner J, McGuire V, Beaton G, Feather T, Mattson FH, Christiansen D, Williams OD. Customary diet, antropometry, and dyslipoproteinemia in selected North American population. Circulation 1986;73(Suppl I):180-190.
46. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 1990;10:520-530.
47. Pairitz G, Davignon J, Mailloux H. Sing CF. Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic. Am J Hum Genet 1988;43:311-321.
48. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EF. Effect of gender, age and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 1987;7:483-490.
49. Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 1984;4:225-231.
50. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary hearth disease risk. Circulation 1990;82:495-506.